Search - tctmd.com

Displaying 541 - 560 of 1032

Sort: Relevancy | Date

Presentation TCT 2016

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Alexandre Abizaid

October 31, 2016

Presentation TCT 2016

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Jo Simonsen

October 31, 2016

Presentation TCT 2016

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Jo Simonsen

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Inspiron

Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Micell

Presenter: Alexandre Abizaid, Ashok Seth, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Firehawk

Presenter: Alexandre Abizaid, Ashok Seth, Runlin Gao

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Desyne BD

Presenter: Alexandre Abizaid, Ashok Seth, Ricardo A. Costa

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Orbus-Neich Combo

Presenter: Alexandre Abizaid, Ashok Seth, Roxana Mehran

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Biomime

Presenter: Alexandre Abizaid, Ashok Seth

October 31, 2016

Presentation TCT 2016

Device Specifications and Clinical Program Update: Alex

Presenter: Alexandre Abizaid, Ashok Seth, Dariusz Dudek

October 31, 2016

Presentation TCT 2016

Device and Clinical Program Highlights: Abluminus

Presenter: Alexandre Abizaid, Ashok Seth, Dinesh Shah

October 31, 2016

Presentation TCT 2016

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: How Did I Treat?

Presenter: Jun-Jack Cheng, Yoshito Yamamoto, Linda Lison

October 30, 2016

Presentation TCT 2016

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: Case Introduction

Presenter: Jun-Jack Cheng, Yoshito Yamamoto, Linda Lison

October 30, 2016

Presentation TCT 2016

Conclusion and Take-home Message

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Presentation TCT 2016

Late Bioresorbable Scaffold Malapposition and Aneurysm

Presenter: Teguh Santoso, Wasan Udayachalerm, Jun-Jack Cheng

October 30, 2016

Presentation TCT 2016

Treatment of In-Stent Restenosis

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Presentation TCT 2016

Treatment of Bifurcation Stenosis

Presenter: Teguh Santoso, Wasan Udayachalerm

October 30, 2016

Presentation TCT 2016

Treatment of Chronic Total Occlusions

Presenter: Teguh Santoso, Wasan Udayachalerm, Naoki Masuda

October 30, 2016

Presentation TCT 2016

Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)

Presenter: Horst Sievert

October 30, 2016

Presentation TCT 2016

Case Presentations: Heavy Lesion Calcification Is Not a Contraindication for Use of Bioresorbable Scaffolds

Presenter: Mohamed Abdel-Wahab, Philippe Généreux, Manuel Pan

October 30, 2016

Advertisement

FANTOM II: Six-Month and Nine-Month Clinical and Angiographic Results With a Radiopaque Desaminotyrosine Polycarbonate-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

TCT 29: Performance and Healing Patterns After Implantation of a Novel Sirolimus-Eluting Bioresorbable Scaffold. Six-Month Follow-Up by Optical Coherence Tomography in the FANTOM II Study

Device Specifications and Clinical Program Update: Inspiron

Device Specifications and Clinical Program Update: Micell

Device Specifications and Clinical Program Update: Firehawk

Device Specifications and Clinical Program Update: Desyne BD

Device Specifications and Clinical Program Update: Orbus-Neich Combo

Device Specifications and Clinical Program Update: Biomime

Device Specifications and Clinical Program Update: Alex

Device and Clinical Program Highlights: Abluminus

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: How Did I Treat?

Case #2 (From Indonesia): Bioresorbable Scaffold for Treatment of Highly-Calcified Diffuse Stenosis: Case Introduction

Conclusion and Take-home Message

Late Bioresorbable Scaffold Malapposition and Aneurysm

Treatment of In-Stent Restenosis

Treatment of Bifurcation Stenosis

Treatment of Chronic Total Occlusions

Prospective Single Center First-in-Human (FIH) Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder With Bioresorbable Framework in Patients With Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)

Case Presentations: Heavy Lesion Calcification Is Not a Contraindication for Use of Bioresorbable Scaffolds

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content